Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxycodone vs Sufentanil for Intubation Stress in CHD
NCT04121416Completed
- Sponsor
- Shengjing Hospital of China Medical University
- Start
- Apr 2019
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of oxycodone in coronary heart disease (CHD) (2 arms), sponsored by Shengjing Hospital of China Medical University. Primary endpoint: Blood Pressure (SBP, DBP, MAP). Started Apr 2019; status: completed.
02
Drugs
oxycodone
03
Conditions
coronary heart disease (CHD)
Beyond the preview
Go deeper on NCT04121416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04121416.